BIOPHARM CMC CONSULTANTS                                 BPCMCC, INC.

  • Home
  • About BPCMCC, INC.
  • Consulting Services
  • Early Clinical Projects
  • Phase 3 & Commercial Projects
  • Contact

Early Clinical Projects

Raw Materials & Equipment Projects

Picture
Supported a start-up with sources for lipids and liposomes and drafted an overview of manufacture and testing. 

Reviewed drawings and supplied suggestions for equipment to enhance the build-out of a biological pilot plant.

Supported a Phase 1 company with a bag manifold design allowing aseptic processing and product sampling.

                                                            Identified process equipment for cell lysis and for rapid low shear mixing.

                                                            Supplied options for testing of incoming raw materials.




Process Development Projects

Picture
Reviewed fermentation and expression data, and suggested modifications for increased host stability.

Designed a successful selection procedure to isolate a stable high protein production strain.

Supported a single chain antibody company with process review and modifications to ensure increased yields and more robust production for clinical material.

                                                            Analyzed data and supported the development of saleable process for  purification  of a clinical
                                                            antibody product.


                                                            Defined optimum chromatography resin for product purification



Clinical Manufacturing Projects

Picture
Identified the appropriate CMO for multiple BioPharm companies needing clinical material.

Supplied companies with options for Process Development and Contract Testing Labs. 

Drafted Batch Records and SOPs to support manufacturing activities.

Successfully supported CMO and CTL technology transfers for multiple companies.

                                                           Supported early clinical companies with process issue resolution at CMOs.
                                                                    
                                                           Reviewed INDs and associated regulatory documents, supported pre-IND preparations.